Accerlerate Diagnostics (AXDX) Holder Selkirk Management Lowered Holding by $2.04 Million as Market Valuation Declined; Tctc Holdings Has Boosted Its Comcast New (CMCSA) Holding by $641,000 as Shares Declined

April 17, 2018 - By Louis Casey

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Logo

Tctc Holdings Llc increased its stake in Comcast Corp New (CMCSA) by 6.53% based on its latest 2017Q4 regulatory filing with the SEC. Tctc Holdings Llc bought 16,025 shares as the company’s stock declined 19.10% with the market. The institutional investor held 261,530 shares of the television services company at the end of 2017Q4, valued at $10.47 million, up from 245,505 at the end of the previous reported quarter. Tctc Holdings Llc who had been investing in Comcast Corp New for a number of months, seems to be bullish on the $155.73B market cap company. The stock increased 1.54% or $0.51 during the last trading session, reaching $33.53. About 13.80M shares traded. Comcast Corporation (NASDAQ:CMCSA) has declined 11.10% since April 17, 2017 and is downtrending. It has underperformed by 22.65% the S&P500.

Selkirk Management Llc decreased its stake in Accerlerate Diagnostics Inc (AXDX) by 17.83% based on its latest 2017Q4 regulatory filing with the SEC. Selkirk Management Llc sold 78,450 shares as the company’s stock declined 17.34% with the market. The hedge fund held 361,550 shares of the capital goods company at the end of 2017Q4, valued at $9.47M, down from 440,000 at the end of the previous reported quarter. Selkirk Management Llc who had been investing in Accerlerate Diagnostics Inc for a number of months, seems to be less bullish one the $1.36B market cap company. The stock increased 0.41% or $0.1 during the last trading session, reaching $24.3. About 121,332 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has declined 0.88% since April 17, 2017 and is downtrending. It has underperformed by 12.43% the S&P500.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.82, from 1.63 in 2017Q3. It worsened, as 21 investors sold AXDX shares while 32 reduced holdings. 15 funds opened positions while 28 raised stakes. 19.90 million shares or 6.66% less from 21.32 million shares in 2017Q3 were reported. California State Teachers Retirement Sys owns 0% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 41,156 shares. Metropolitan Life Ny reported 8,727 shares or 0% of all its holdings. Voya Invest reported 0% stake. Ironwood Finance Ltd Company reported 0.03% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Deutsche Comml Bank Ag invested in 0.01% or 312,470 shares. 26,635 were accumulated by Cutter & Brokerage. Selkirk Mgmt Lc invested in 361,550 shares. Trellus Management Co Limited owns 8,678 shares for 0.31% of their portfolio. Loomis Sayles LP stated it has 631,586 shares. State Board Of Administration Of Florida Retirement accumulated 16,068 shares or 0% of the stock. Arrowmark Colorado Llc holds 934,252 shares. Oz Management Ltd Partnership accumulated 0.01% or 53,100 shares. Wells Fargo Mn, California-based fund reported 61,632 shares. State Common Retirement Fund has 27,900 shares for 0% of their portfolio. Royal Bancorp Of Canada reported 3,168 shares stake.

Selkirk Management Llc, which manages about $168.83 million and $187.30 million US Long portfolio, upped its stake in Chegg Inc (NYSE:CHGG) by 60,000 shares to 328,000 shares, valued at $5.35M in 2017Q4, according to the filing.

Analysts await Accelerate Diagnostics, Inc. (NASDAQ:AXDX) to report earnings on May, 4. They expect $-0.31 earnings per share, down 14.81% or $0.04 from last year’s $-0.27 per share. After $-0.27 actual earnings per share reported by Accelerate Diagnostics, Inc. for the previous quarter, Wall Street now forecasts 14.81% negative EPS growth.

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 3 by Piper Jaffray. The rating was initiated by JP Morgan with “Overweight” on Thursday, March 24. Piper Jaffray maintained the stock with “Buy” rating in Sunday, September 17 report. BTIG Research upgraded Accelerate Diagnostics, Inc. (NASDAQ:AXDX) on Tuesday, August 25 to “Neutral” rating. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Overweight” rating by Piper Jaffray on Wednesday, December 16. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Buy” rating by BTIG Research on Wednesday, July 12. The company was maintained on Tuesday, August 9 by JP Morgan. The stock of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) earned “Neutral” rating by BTIG Research on Wednesday, December 13. William Blair initiated the shares of AXDX in report on Friday, January 8 with “Outperform” rating.

Since October 17, 2017, it had 5 insider buys, and 0 selling transactions for $1.50 million activity.

Since December 14, 2017, it had 0 insider buys, and 10 sales for $62.55 million activity. On Thursday, March 22 BLOCK ARTHUR R sold $635,776 worth of Comcast Corporation (NASDAQ:CMCSA) or 18,839 shares. Murdock Daniel C. sold $67,320 worth of stock or 1,891 shares. WATSON DAVID N also sold $4.84 million worth of Comcast Corporation (NASDAQ:CMCSA) on Tuesday, March 6. ROBERTS BRIAN L sold $22.57 million worth of stock or 583,835 shares.

Among 32 analysts covering Comcast Corporation (NASDAQ:CMCSA), 23 have Buy rating, 1 Sell and 8 Hold. Therefore 72% are positive. Comcast Corporation had 82 analyst reports since July 27, 2015 according to SRatingsIntel. On Thursday, August 3 the stock rating was upgraded by Guggenheim to “Buy”. Nomura initiated the shares of CMCSA in report on Tuesday, December 8 with “Buy” rating. As per Wednesday, November 11, the company rating was initiated by Suntrust Robinson. Pivotal Research maintained it with “Buy” rating and $4800 target in Thursday, July 27 report. The rating was maintained by Jefferies on Monday, December 19 with “Buy”. The firm has “Neutral” rating by Instinet given on Thursday, January 18. Buckingham Research maintained the shares of CMCSA in report on Monday, January 8 with “Buy” rating. The company was maintained on Monday, June 26 by Pivotal Research. The rating was maintained by SunTrust with “Buy” on Thursday, October 26. The rating was upgraded by Deutsche Bank to “Buy” on Friday, January 13.

Comcast Corporation (NASDAQ:CMCSA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: